Cardiovascular disease market set to grow to $146.4 bn by 2022: GBI Research
The cardiovascular disease market, which includes hypertension, dyslipidemia, and thrombotic events, is set to grow from $129.2…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
‘GDP is the heart of the quality system’
Any inaccuracies in Good Documentation Practice (GDP) can have an adverse impact on auditing process. Bhavan (Bob) Mehta,…
Asia-Pacific gastric cancer market set to experience strong growth to $2.7 billion by 2022: GBI…
Market will be driven by the increasing prevalence of gastric cancer, higher levels of health insurance coverage, and improving…
Infectious diseases POCT market will rise to over $1.17 bn by 2022: GlobalData
It will be driven by factors including increasing prevalence of infectious diseases, the emergence of more accurate molecular…
Countering the Chinese threat
With the Indian government coming up with a slew of measures to counter the Chinese invasion in bulk drug manufacturing, can drug…
Is herbal the future of excipients?
Advantages such as low cost and less toxicity, which give them an edge over their synthetic counterparts, are spurring the use of…
Balancing growth with operations
SynCore Consulting helped a fast growing pharma retail chain, bogged down by snags in its distribution model, improve stock…
Cystic fibrosis therapies will push Vertex ahead of GSK in $46.6 billion respiratory market by 2022:…
It will grow at a CAGR of 7.5 per cent
VTE therapeutics market set to hit $3.7 billion by 2025: GlobalData
It will represent a CAGR of 2.89 per cent
Newer therapies will steer Type II diabetes market in South-East Asia
The market will see a rise from $1.7 billion in 2015 to $2.7 billion by 2022, says GBI Research
Atrial fibrillation market will peak in 2022
The market will however see a rapid decline to $4.9 billion by 2025, says GlobalData
Race Against Time
Pharma companies across the world are racing against time to
meet the November 2017 deadline of the US DSCSA followed
by the…
Serialisation world – A global regulatory canvas
Arjun Guha Thakurta, Director – Operations, Life Science Consulting, (a Convalgroup Company) gives an insight about the impact of…
Challenges of global track and trace: Holistic approach, common solution
The objective of global track and trace regulations is to protect patient safety by preventing counterfeit, diversion of products…
Recipharm announces global serialisation collaboration
Partners with Marchesini, SEA Vision and TraceLink
Aesica Pharmaceuticals meets serialisation challenges
The company is currently applying its novel solution to enable customers to meet the specific serialisation demands of China and…
Brexit impact: Should the Indian pharma industry worry?
Sameer Walia, Managing Director, The Smart Cube examines the potential implications of Brexit on the overall pharma industry in…
Major players in Type II diabetes shifting focus to pricing to maintain market share
According to a report by GlobalData, human insulins and many insulin analogs are currently off patent or will soon lose their…
GSK’s vaccine set to revolutionise meningococcal disease prevention market
GlobalData report mentions that of the three major meningococcal vaccines currently being developed in the 8MM, only…
Pharma industry licensing deals soared to record $46.2 billion in 2015
According to GlobalData whitepaper, there has been a surge in investment of deals in the Immuno-Oncology (I-O) space over the past…